Pipobroman - Generic Drug Details
✉ Email this page to a colleague
What are the generic drug sources for pipobroman and what is the scope of patent protection?
Pipobroman
is the generic ingredient in one branded drug marketed by Abbott and is included in one NDA. Additional information is available in the individual branded drug profile pages.Summary for pipobroman
US Patents: | 0 |
Tradenames: | 1 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 68 |
Clinical Trials: | 3 |
Patent Applications: | 7,316 |
DailyMed Link: | pipobroman at DailyMed |
Recent Clinical Trials for pipobroman
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Novartis | Phase 2 |
RWTH Aachen University | Phase 2 |
Novartis Pharmaceuticals | Phase 2 |
Medical Subject Heading (MeSH) Categories for pipobroman
Anatomical Therapeutic Chemical (ATC) Classes for pipobroman
US Patents and Regulatory Information for pipobroman
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Abbott | VERCYTE | pipobroman | TABLET;ORAL | 016245-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Abbott | VERCYTE | pipobroman | TABLET;ORAL | 016245-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |